Tricuspid valve disease: updates on diagnostic imaging and intervention
Por:
Grapsa, J, Zancanaro, E, Rommel, KP, Weber, L, Coisne, A, Estevez-Loureiro, R, Delgado, V, Sitges, M, Enriquez-Sarano, M, Praz, F, Fam, N, Cristell, N, Latib, A, Piazza, N, Lurz, P, Modine, T, Hausleiter, J, Hahn, RT, Leon, MB and Granada, JF
Publicada:
2 ene 2026
Ahead of Print:
1 ene 2026
Resumen:
Tricuspid regurgitation is associated with an increased risk of hospitalization and death. Many patients with severe tricuspid regurgitation are unable to undergo surgical intervention owing to prohibitive technical or clinical risk. The past two decades has seen an outburst of technological advances in the field of transcatheter tricuspid technologies, with numerous randomized, controlled trials assessing the safety and efficacy of various repair and replacement therapies for tricuspid regurgitation. However, crucial knowledge gaps persist, particularly in areas such as patient selection, anatomical eligibility and the haemodynamic effects of device implantation. In this Review, we outline the anatomical features of the tricuspid valve and the haemodynamic consequences of tricuspid regurgitation, and we summarize the imaging modalities used for diagnosis and management. Furthermore, we detail the current guideline-directed medical therapy for tricuspid regurgitation, as well as valve repair and replacement surgical procedures being tested in clinical trials. Finally, we highlight future technological innovations that promise to optimize diagnosis, patient selection and the device development process.
Filiaciones:
Grapsa, J:
Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Inst, Mass Gen Brigham, Boston, MA 02115 USA
Zancanaro, E:
Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Inst, Mass Gen Brigham, Boston, MA 02115 USA
Johannes Gutenberg Univ Mainz, Fac Med, Dept Cardiac & Vasc Surg, Mainz, Germany
Univ Hosp Mainz, Mainz, Germany
Osped San Raffaele, Dept Cardiac Surg, Milan, Italy
Rommel, KP:
Johannes Gutenberg Univ Mainz, Fac Med, Dept Cardiac & Vasc Surg, Mainz, Germany
Univ Hosp Mainz, Mainz, Germany
Weber, L:
CHU Bordeaux, Hop Cardiol Haut Leveque, Bordeaux, France
Kantonsspital St Gallen, Dept Cardiol, St Gallen, Switzerland
Coisne, A:
Univ Lille, Inserm, CHU Lille, Inst Pasteur Lille, Lille, France
Estevez-Loureiro, R:
Univ Hosp Alvaro Cunqueiro, Dept Cardiol, Vigo, Spain
:
Germans Trias i Pujol Univ Hosp, Heart Inst, Dept Cardiol, Barcelona, Spain
Sitges, M:
Univ Barcelona, Hosp Clin, Cardiovasc Inst, Barcelona, Spain
Enriquez-Sarano, M:
Minneapolis Heart Inst, Minneapolis, MN USA
Praz, F:
Univ Klin Kardiol, Inselspital Bern, Bern, Switzerland
Fam, N:
St Micheals Hosp, Toronto, ON, Canada
Cristell, N:
Cardiovasc Res Fdn, New York, NY USA
Latib, A:
Albert Einstein Coll Med, Montefiore Einstein Ctr Heart & Vasc Care, Montefiore Med Ctr, New York, NY USA
Piazza, N:
McGill Univ, Hlth Ctr, Montreal, PQ, Canada
Lurz, P:
Univ Med Ctr Mainz, Dept Cardiol, Mainz, Germany
Modine, T:
CHU Bordeaux, Hop Cardiol Haut Leveque, Bordeaux, France
Hausleiter, J:
LMU Munchen, LMU Klinikum, Med Klin & Poliklin 1, Munich, Germany
German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany
Hahn, RT:
Cardiovasc Res Fdn, New York, NY USA
Columbia Univ, Med Ctr, NewYork Presbyterian, New York, NY USA
Leon, MB:
Columbia Univ, Med Ctr, NewYork Presbyterian, New York, NY USA
Granada, JF:
Cardiovasc Res Fdn, New York, NY USA
|